Implantica submits U.S. FDA Premarket Approval (PMA) Application for RefluxStop® (first module): https://lnkd.in/gErAZfi5
Congratulations Susana Mogensen, Ph.D. and the team! 🎉
Congratulations!
Skip to main content
Implantica submits U.S. FDA Premarket Approval (PMA) Application for RefluxStop® (first module): https://lnkd.in/gErAZfi5
Team Lead at Skills Alliance Working in Quality Assurance and Regulatory Affairs Within Medical Devices Across Europe
3moCongratulations Susana Mogensen, Ph.D. and the team! 🎉
Award-winning medical writer for pharmaceutical and medical device audiences 🐁 AI (artificial intelligence) proponent 🐁 Biology and psychology adjunct 🐁 Oddest superpower: perfect pitch (music)
3moCongratulations!
To view or add a comment, sign in
A recent cost-effectiveness analysis from the perspective of the UK National Health Service determined that RefluxStop™ is likely to provide a net monetary benefit of £31,797 as compared to magnetic sphincter augmentation over a patient's lifetime.¹ Additionally, since RefluxStop™ does not encircle the food passageway, patients who are not candidates for traditional surgical options of the past could possibly be candidates for a durable surgical treatment for GORD with RefluxStop.™ Learn more at the Scientific Publications page: https://lnkd.in/gp3vGV3Y *RefluxStop™ is not available for sale in the US and Canada. Contact Implantica for availability in your region. customer.support@implantica.com
To view or add a comment, sign in
We were thrilled to see RefluxStop™ in this story in Medical Device Network of the first RefluxStop™ procedure completed with robotic surgery in the UK, at University Hospital Southampton NHS FT: https://lnkd.in/g_xksd_t
To view or add a comment, sign in
Are you a skilled Administrative Assistant in Zug ready for a part-time opportunity? We want to meet you! Apply today: https://lnkd.in/g67huTmg #AdministrativeAssistant #Opportunity #Career #SwissJobs
To view or add a comment, sign in
This abstract, based on a chart review of 79 RefluxStop® patients, was presented by Dr. med. Thorsten Lehmann as a poster at Digestive Disease Week® (DDW) 2024. Postoperatively, the mean GERD-HRQL (GERD-related quality of life) score significantly improved by 92.6% (p<.05). See the abstract: https://lnkd.in/gi_SSujQ
To view or add a comment, sign in
How bad can GERD get? This story from BBC News gives insights on the profoundly negative impact of GERD on a patient's life: https://lnkd.in/gjnXBzYu
To view or add a comment, sign in
About 14.5% of UK adults struggle with gastroesophageal reflux disease (GORD), it's very common and innovative treatments are urgently needed. RefluxStop™ offers a new surgical treatment that does not encircle the food passageway, now making a durable surgical treatment available to a whole new group of patients who were not candidates for traditional GORD surgery. Learn more about the RefluxStop™ procedure at our Scientific Publications and Abstracts page: https://lnkd.in/gp3vGV3Y
To view or add a comment, sign in
Looking for an opportunity to join an exciting and growing company in Malta? We're looking for a Bookkeeper, apply today! https://lnkd.in/g8KHdxpm #Career #Bookkeeper #MaltaJobs
To view or add a comment, sign in
🚀 Felicitaciones al Dr. Daniel Sánchez y al Dr. Pablo Priego de Cirugia Laparoscopia Madrid por realizar los dos primeros procedimientos RefluxStop™ en un hospital privado de España en el Hospital Viamed Santa Elena la semana pasada. Estamos orgullosos de trabajar con cirujanos como el Dr. Priego y el Dr. Sánchez que adoptan la innovación y la última tecnología en el tratamiento quirúrgico de la ERGE. Este es un hito importante para llevar Refluxstop™ a más pacientes en España y más allá. Obtenga más información sobre RefluxStop™ en nuestra página de Resúmenes y publicaciones científicas: https://lnkd.in/gp3vGV3Y 🚀 Congratulations to Dr. Daniel Sanchez and Dr. Pablo Priego of CIRUGIA LAPAROSCOPICA MADRID on performing the first two RefluxStop™ procedures at a private hospital in Spain at Hospital Viamed Santa Elena last week. We are proud to work with surgeons like Dr. Priego and Dr. Sanchez who embrace innovation and the latest technology in the surgical treatment of GERD. This is an important milestone in bringing Refluxstop™ to more patients in Spain and beyond. Learn more about RefluxStop™ at our Scientific Publications & Abstracts page: https://lnkd.in/gp3vGV3Y
To view or add a comment, sign in
A study published in the Journal of Neurogastroenterolgy and Motility showed that the fastest growing age group of GERD patients is 30-39 years.¹ It's important to treat symptoms such as heartburn seriously, especially in younger men, as longstanding GERD may progress to diseases such as Barrett's esophagus and esophageal cancer. As we wrap up Men's Health Month, we want to remind men to take time out to take care of themselves. See the study about trends in GERD patient ages: https://lnkd.in/gCeT8C7D #MensHealthMonth #GERD
To view or add a comment, sign in
An inspiring story of RefluxStop™ at the University Hospital Southampton NHS FT in LADbible from LADbible Group https://lnkd.in/gHAGuYsC *RefluxStop™ is not available for sale in the US and Canada. Contact Implantica for availability in your region. customer.support@implantica.com
To view or add a comment, sign in
Medical Device Regulatory Affairs, Software, AI and Risk Management expert. TC contributing member for Ireland on IEC 62304 and IEC 63450
3moCongratulations Susana.mogensen@implantica.com and team. Significant milestone achieved.